Literature DB >> 3279961

Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.

M J Walport1, P J Lachmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3279961     DOI： 10.1002/art.1780310201

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  22 in total

1.  Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE).

Authors:  M Kawano; T Seya; I Koni; H Mabuchi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).

Authors:  Robert J Boackle; Quang L Nguyen; Renata S Leite; Xiaofeng Yang; Jana Vesely
Journal:  Mol Immunol       Date:  2005-03-05       Impact factor: 4.407

3.  Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients.

Authors:  J E Teixeira; R Martinez; L M Câmara; J E Barbosa
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

4.  Mapping of the human 60,000 M(r) Ro/SSA locus: the genes for three Ro/SSA autoantigens are located on separate chromosomes.

Authors:  M B Frank; M G Mattei
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.

Authors:  Kazi Abdus Salam; Richard Y Wang; Teresa Grandinetti; Valeria De Giorgi; Harvey J Alter; Robert D Allison
Journal:  Hepatology       Date:  2018-11-01       Impact factor: 17.425

6.  Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.

Authors:  P Cornillet; P Gredy; J L Pennaforte; O Meyer; M D Kazatchkine; J H Cohen
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?

Authors:  R Lahesmaa; E Eerola; A Toivanen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

8.  Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).

Authors:  J H Cohen; H U Lutz; J L Pennaforte; A Bouchard; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

9.  An anti-peptide antibody that recognizes a neo-antigen in the CR1 stump remaining on erythrocytes after proteolysis.

Authors:  J E Barbosa; R A Harrison; P J Barker; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

10.  A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.

Authors:  Daniel J Birmingham; Fawzi Irshaid; Katherine F Gavit; Haikady N Nagaraja; C Yung Yu; Brad H Rovin; Lee A Hebert
Journal:  Mol Immunol       Date:  2007-04-30       Impact factor: 4.407
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.